Is a complete ACTU research report available?

No complete published report is available for Actuate Therapeutics, Inc. (ACTU) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Actuate Therapeutics, Inc. (ACTU)

NASDAQ: ACTU · USD

$1.17

+0.09 (+8.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ACTU analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	28M
Net income (ttm)	-21.5M
EPS (ttm)	-$0.98
Shares out	23.9M
Volume	269,386
Price target	$9.98	+753.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -21.5M
EPS (ttm): -$0.98
Market cap: 28M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ACTU indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001652935
Company name	Actuate Therapeutics, Inc.
Country	United States
Country code	US
Cusip	005083100
Employees	12
Employees Change	2%
Employees Change Percent	20
Enterprise value	$19.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-08-13
Isin	US0050831009
Last refreshed	2026-07-31
Market cap	$28M
Market cap category	Nano-Cap
Price	$1.17
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	ACTU
Website	https://actuatetherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-76.93%
P/B ratio	7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-21.5M
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Profit Per Employee	$-1.8M
ROA	-203.8
ROCE	-521.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-82.74%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.9M
Cash	$8.1M
Current Assets	$8.5M
Current Liabilities	$4.7M
Debt	$0
Equity	$3.8M
Interest Coverage	-1,078.4
Liabilities	$5.1M
Long Term Assets	$391,838
Long Term Liabilities	$404,991
Net Cash	$8.1M
Net Cash By Market Cap	$29.06
Net Cash Growth	109.13%
Net Debt Equity	$-2.15
Tangible Book Value	$3.8M
Tangible Book Value Per Share	$0.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.8
Net Working Capital	$-4.3M
Quick ratio	1.72
Working Capital	$3.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-71.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-82.72%
200-day SMA	4.04
50-day SMA	1.74
50-day SMA vs 200-day SMA	50under200
All Time High	11.99
All Time High Change	-90.24%
All Time High Date	2025-05-30
All Time Low	1.03
All Time Low Change	13.59%
All Time Low Date	2026-07-28
ATR	0.19
Beta1y	1.89
Beta2y	1.39
Ch YTD	-80.88
High	1.19
High52	9.22
High52 Date	2025-09-04
High52ch	-87.31%
Low	1.06
Low52	1.03
Low52 Date	2026-07-28
Low52ch	13.59%
Ma50ch	-32.68%
Premarket Change Percent	4.63
Premarket Price	$1.13
Premarket Volume	545
Price vs 200-day SMA	-71%
RSI	36.83
RSI Monthly	33.96
RSI Weekly	29.38
Sharpe ratio	-1.41x
Sortino ratio	-1.94
Total Return	-71.27%
Tr YTD	-80.88
Tr1m	-25.95%
Tr1w	-7.14%
Tr3m	-59.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$15
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.2
Operating Income	$-21.8M
Price target	$9.98
Price Target Change	$753
Price Target Change Top	$1,182

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,571,558%
Float Percent	35.83%
Shares Insiders	5.12%
Shares Institutions	8.94%
Shares Out	23,925,852
Shares Qo Q	0.04%
Shares Yo Y	71.27%
Short Float	8.81%
Short Ratio	1.72
Short Shares	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-25,882,789
Average Volume	441,029.4x
Bv Per Share	0.16
Ch1m	-25.95
Ch1w	-7.14
Ch1y	-82.72
Ch3m	-59.38
Ch6m	-75.32
Change	8.33%
Change From Open	7.34
Close	1.08
Days Gap	0.93
Dollar Volume	315,181.6
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-21.8M
EBITDA	$-21.8M
EPS	$-0.98
F Score	2
Financing CF	23,849,439
Fiscal Year End	December
Founded	2,015
Ipr	-85.38
Iprfo	-88.16
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma150	3.08
Ma150ch	-62.06%
Ma20	1.36
Ma20ch	-13.91%
Net CF	4,244,599
Next Earnings Date	2026-08-13
Open	1.09
Optionable	No
Position In Range	84.62
Post Close	1.17
Postmarket Change Percent	1.57
Postmarket Price	$1.19
Pre Close	1.08
Price Date	2026-07-30
Ptbv Ratio	7.4
Relative Volume	0.61x
Share Based Comp	6,277,949
Tr6m	-75.32%
Us State	Texas
Volume	269,386

Actuate Therapeutics, Inc. (ACTU)

Coverage state: Market snapshot only — no published research

Generate the first ACTU analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACTU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACTU indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACTU

Frequently asked questions